Jade Biosciences, Inc. JBIO

Updated: 8 Aug 2026

NASDAQ | Biotech | Biotechnology and autoimmune therapies

No signal published yet

We already track Jade Biosciences and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Jade Biosciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and autoimmune therapies
We're already tracking Jade Biosciences, Inc. — here are the latest events we've registered

Recent News

  • On June 26, 2026, Jade Biosciences announced the appointment of Mark Eisner to its Board of Directors. Earlier in June 2026, the company completed a public offering of common stock, raising approximately $172.5 million to fund clinical trials and pipeline development.

What Firelda Watch includes for Jade Biosciences, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Jade Biosciences, Inc. will be delivered in the same format.

Want to follow Jade Biosciences, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Jade Biosciences free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Jade Biosciences, Inc. JBIO
Jade Biosciences — follow and we'll monitor it
Follow Jade Biosciences free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.